TENAX THERAPEUTICS, INC. Notes Payable, Current
TENAX THERAPEUTICS, INC. (TENX) had Notes Payable, Current of $0 as of 2024-12-31, per its 10-K filed 2025-03-25.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2025-03-25
- 2024-12-31: Notes Payable, Current $0.00.
- 2024-09-30: Notes Payable, Current $0.00.
- 2024-06-30: Notes Payable, Current $278.80K.
- 2024-03-31: Notes Payable, Current $413.17K.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-25 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $278.80K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $413.17K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $501.00K 10-K · filed 2025-03-25 | $513.91K 10-Q · filed 2023-05-15 |
| 2023-09-30 | $174.47K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $345.75K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $513.91K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $624.30K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $46.12K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $91.88K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $228.76K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-10 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $213.58K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $120.49K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $30.90K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $107.61K 10-Q · filed 2020-08-14 | |
| 2019-12-31 | $0.00 10-K/A · filed 2021-04-16 | |
| 2015-10-31 | $0.00 10-Q · filed 2015-12-10 | |
| 2015-07-31 | $48.38K 10-Q · filed 2015-09-09 | |
| 2015-04-30 | $100.16K 10-KT · filed 2016-03-14 | |
| 2015-01-31 | $151.25K 10-Q · filed 2015-03-17 | |
| 2014-10-31 | $0.00 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $16.01K 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $346.89K 10-KT · filed 2016-03-14 | |
| 2014-01-31 | $368.77K 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $233.32K 10-Q · filed 2013-12-17 | |
| 2013-07-31 | $3.43M 10-Q · filed 2013-09-17 | |
| 2013-04-30 | $57.54K 10-K · filed 2014-07-29 | |
| 2013-01-31 | $98.66K 10-Q · filed 2013-03-18 | |
| 2012-10-31 | $7.20K 10-Q · filed 2012-12-14 | |
| 2012-07-31 | $21.22K 10-Q · filed 2012-09-19 | |
| 2012-04-30 | $62.96K 10-K · filed 2013-06-26 | |
| 2012-01-31 | $104.18K 10-Q · filed 2012-03-15 | |
| 2011-10-31 | $7.20K 10-Q · filed 2011-12-15 | |
| 2011-07-31 | $16.30K 10-Q · filed 2011-09-19 | |
| 2011-04-30 | $43.30K 10-K · filed 2012-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |